HB Wealth Management LLC raised its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 58.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,270 shares of the semiconductor company’s stock after purchasing an additional 2,691 shares during the period. HB Wealth Management LLC’s holdings in Synopsys were worth $2,882,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the stock. Sankala Group LLC acquired a new stake in shares of Synopsys during the 4th quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new position in Synopsys in the 4th quarter valued at about $28,000. Caitong International Asset Management Co. Ltd bought a new position in Synopsys in the 4th quarter valued at about $28,000. Atlas Capital Advisors Inc. bought a new position in Synopsys in the 4th quarter valued at about $32,000. Finally, Osbon Capital Management LLC acquired a new stake in Synopsys during the fourth quarter worth approximately $34,000. 85.47% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities analysts have recently commented on SNPS shares. Needham & Company LLC reaffirmed a “buy” rating and issued a $580.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Berenberg Bank set a $633.00 price target on Synopsys in a report on Wednesday, May 27th. Robert W. Baird set a $558.00 price target on Synopsys in a research note on Thursday, May 28th. Wells Fargo & Company upped their price objective on Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Finally, Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $450.00 to $550.00 in a research report on Tuesday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $570.06.
Synopsys Stock Performance
Shares of NASDAQ:SNPS opened at $437.16 on Monday. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73. The company’s 50 day moving average price is $482.19 and its two-hundred day moving average price is $461.39. The firm has a market cap of $83.71 billion, a PE ratio of 101.19, a PEG ratio of 2.57 and a beta of 1.22. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm’s quarterly revenue was up 41.9% on a year-over-year basis. During the same period in the previous year, the business earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current year.
Insider Buying and Selling at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Visa’s Open USD Push Puts Circle’s Stablecoin Moat Under Pressure
- This Under-the-Radar Industrial Is Quietly Powering AI
- Why Microsoft Looks Like the Best Big Tech Trade for H2 2026
- Strategy’s Bitcoin Pivot Gives Investors a New Reason to Watch Preferred Shares
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
